Nuvation Bio, Inc. (NUVB)
8.96
+0.02
(+0.22%)
USD |
NYSE |
Dec 31, 16:00
8.96
0.00 (0.00%)
After-Hours: 20:00
Nuvation Bio EPS Diluted (Quarterly): -0.163 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Indivior PLC | 0.3256 |
| Terns Pharmaceuticals, Inc. | -0.2686 |
| GRAIL, Inc. | -2.463 |
| Arrowhead Pharmaceuticals, Inc. | -0.175 |
| Nektar Therapeutics | -1.875 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -55.79M |
| Revenue (Quarterly) | 13.12M |
| Total Expenses (Quarterly) | 68.91M |
| Enterprise Value | 2.731B |
| Gross Profit Margin (Quarterly) | 70.40% |
| Profit Margin (Quarterly) | -425.2% |
| Earnings Yield | -7.15% |
| Normalized Earnings Yield | -7.125 |